Physician profile
Taylor Mcdowell
NPI 1194354845
$2,607.75
in general payments reported to CMS, 2019-2025
17 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.67 · 2022: $1,055 · 2023: $642 · 2024: $704 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $985.80 | 2022-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $777.45 | 2022-2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $155.33 | 2021-2025 | Austedo, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $83.41 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.10 | 2022-2023 | Trintellix, Takhzyro |
| Abbvie INC. | $77.36 | 2022-2023 | |
| Vanda Pharmaceuticals INC. | $75.06 | 2021-2022 | |
| Neuronetics, INC. | $61.61 | 2022 | |
| Alkermes, INC. | $60.62 | 2022-2024 | Aristada, Lybalvi |
| Tris Pharma INC | $48.70 | 2023 | Dyanavel Xr |
| Exact Sciences Corporation | $47.39 | 2024-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $47.10 | 2024 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $31.55 | 2025 | |
| Idorsia Pharmaceuticals US INC | $21.30 | 2022 | |
| Ironshore Pharmaceuticals INC. | $19.60 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $18.72 | 2022 | |
| Neurocrine Biosciences, INC. | $17.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Mcdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.